Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FCRM5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,944
Award facts
- Contract value 100% obligated
- $15,944.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $15,944.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on December 5, 2025, with an ultimate completion date of December 29, 2025, carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and executed under the company's existing indefinite delivery contract.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the federal pharmaceutical supply chain, with consistent performance across multiple therapeutic categories and product lines since its System for Award Management registration in July 2001.
Quick answers
Who was awarded contract SPE2DR26FCRM5?
SPE2DR26FCRM5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FCRM5 worth?
The government has obligated $15,944 on SPE2DR26FCRM5.
Is contract SPE2DR26FCRM5 an order under another contract?
Yes. SPE2DR26FCRM5 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRM5 competed?
The extent of competition for SPE2DR26FCRM5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award